Editor: Atta-ur-Rahman / Khurshid Zaman

Topics in Anti-Cancer Research

Volume 2

eBook: US $129 Special Offer (PDF + Printed Copy): US $232
Printed Copy: US $168
Library License: US $516
ISSN: 2468-5860 (Print)
ISSN: 2213-3585 (Online)
ISBN: 978-1-60805-139-7 (Print)
ISBN: 978-1-60805-136-6 (Online)
Year of Publication: 2013
DOI: 10.2174/97816080513661130201

Introduction

This is the second volume of the Patent eBook Series titled Topics in Anti-Cancer Research. The eBook includes updated chapters on topics relevant to contemporary cancer research published in the journal, Recent Patents on Anti-Cancer Drug Discovery.

This volume covers scientific and patented novel chemotherapeutic agents and drugs for metastatic castration-resistant prostate cancer and Ras/ Raf /MEK/ERK pathway, P1K, AKT and mTORC1/2 inhibitors, ATPase inhibitors for cancer therapy, and sphingomyelin biosynthesis which regulates cancer cell death and growth.

Other chapters also explain research on biochemical regulation i.e. cell cycle and energy metabolism, the role of genetic variations of FcγRs gamma receptors in monoclonal antibody based anti-cancer therapy and effectiveness of antiangiogenic therapy, endogenous angiogenesis inhibitors and anti-angiogenic drugs for the treatment of renal cell carcinoma, prevention of cancer by ribonucleotide reductase, anticancer activity of Erlotinib in glioblastoma and the mechanisms of action of nanodrugs and nano-sized camptothecin drugs in cancer chemotherapy. The volume also covers recent studies in the field of onconutrition. The broad range of topics covered in this second volume will be of immense interest to clinicians, scientists and R&D experts seeking new targets for the prevention of cancer, novel oncogenic biomarkers, and methods for cancer therapy.

Indexed in: Book Citation Index, Science Edition, Chemical Abstracts, BIOSIS Previews, EBSCO, Ulrich's Periodicals Directory.

Foreword

- Pp. i-iii (3)
Atta-ur-Rahman, Khurshid Zaman
Download Free

List of Contributors

- Pp. iv-v (2)
Atta-ur-Rahman, Khurshid Zaman
Download Free

Introduction

- Pp. vi
Atta-ur-Rahman, Khurshid Zaman
Download Free

Emerging Research and Therapeutic Strategies for Castration-Resistant Prostate Cancer

- Pp. 3-34 (32)
Tomoaki Tanaka, Tatsuya Nakatani
View Abstract

Sphingomyelin Biosynthesis Modulates Cancer Cell Death and Growth

- Pp. 35-62 (28)
Elodie Lafont, Kazuyuki Kitatani, Toshiro Okazaki, Bruno Ségui
View Abstract

The Therapeutic Promise of Anti-Cancer Drugs Against the Ras/Raf/MEK/ERK Pathway

- Pp. 63-94 (32)
Erin K. Crane, Kwong-Kwok Wong
View Abstract

Recent Developments in Anticancer Agents Targeting PI3K, AKT and mTORC1/2

- Pp. 95-196 (102)
Irene Brana, Sara De Dosso, Rodrigo Dienstmann, Jordi Rodon, Josep Tabernero, Ben Markman
View Abstract

Cell Cycle and Energy Metabolism in Tumor Cells: Strategies for Drug Therapy

- Pp. 197-230 (34)
Nivea D. Amoêdo, Tatiana El-Bacha Porto, Mariana F. Rodrigues, Franklin D. Rumjanek
View Abstract

V-ATPase Inhibitors in Cancer Therapy: Targeting Intraorganellar Acidification

- Pp. 231-256 (26)
Agustín Hernández, Gloria Serrano-Bueno, Rosana Herrera-Palau, José R. Pérez-Castiñeira, Aurelio Serrano
View Abstract

Insights into the Role of Fc Gamma Receptors (FcγRs) Genetic Variations in Monoclonal Antibody-Based Anti-cancer Therapy

- Pp. 257-278 (22)
Fabio Concetti, Valerio Napolioni
View Abstract

Angiogenesis: Therapeutic Target in Renal Cell Carcinoma

- Pp. 279-298 (20)
Manisha Singh, Sudip Nanda, Santo Longo, Shree G. Sharma
View Abstract

Anti-Angiogenic Therapy for Cancer: Past, Present and Future

- Pp. 299-319 (21)
Boel De Paepe
View Abstract

Paradigm Shift in the Therapeutic Potential of Endogenous Angiogenesis Inhibitors for Cancer Therapy: Historical Perspective and Future Direction

- Pp. 320-362 (43)
Mohanraj Dhanabal, Natarajan Sethuraman
View Abstract

Ribonucleotide Reductase as a Target to Control Cancer Proliferation

- Pp. 363-406 (44)
Nuno M.F.S.A. Cerqueira, Narayana S.H.N. Moorthy, Pedro A. Fernandes, Maria J. Ramos
View Abstract

Enhancing the Anticancer Activity of Erlotinib in Glioblastoma

- Pp. 407-436 (30)
Georg Karpel-Massler, Christian R. Wirtz, Marc-Eric Halatsch
View Abstract

Nanodrugs: Magic Bullets in Cancer Chemotherapy

- Pp. 437-494 (58)
Kishwar Saleem, Waseem A. Wani, Ashanul Haque, Archana Milhotra, Imran Ali
View Abstract

Chemotherapy of Nano-Sized Camptothecin-Derived Drugs

- Pp. 495-521 (27)
Nguyen-Van Cuong, Chi-Hui Guo, Ming-Fa Hsieh
View Abstract

Onconutrition: Redox Chemoprevention by Functional Biomolecules and Biomarker Assessment

- Pp. 522-552 (31)
María D. Defagó, Elio A. Soria
View Abstract

Author Index

- Pp. 553
Atta-ur Rahman, Khurshid Zaman
Download Free

Index

- Pp. 554-576 (23)
Atta-ur Rahman, Khurshid Zaman
Download Free

RELATED BOOKS

.Colorectal Cancer Diagnosis and Therapeutic Updates.
.Nanotherapeutics for the Treatment of Hepatocellular Carcinoma.
.Topics in Anti-Cancer Research.
.Frontiers in Clinical Drug Research - Anti-Cancer Agents.